Naloxone Market – Pharmaceutical Industry becomes an Extensive Consumer of Naloxone

The demand within the global naloxone market has been rising on account of the efforts of the pharmaceutical industry to prevent the ill-effects of drugs overdose. Opiod is a class of drugs that can have severe implications for individuals if consumed in ireegulated amounts, and hence, there is a need to counter over-dosage of opiods. Naloxone is a drug that can effectively suppress the effect of opiod, and for this reason, the demand for naloxone across the pharmaceutical industry has been rising at a stellar rate. Opiods are often mixed with naloxone in order to give a balanced drug dose to patients, and this trend has greatly helped in countering opiod overdose.

The global naloxone market can be segmented on the basis of the following critetia: by formulation, by end-user, and by region. The multiplicity of application of naloxone necessitates a core understanding of the global market for naloxone in order to get a peek into the forces of demand and supply.

Know the Growth Opportunities in Emerging Markets

A report on the global naloxone market is a deft explanation of the dynamics that have aided the growth of the global market for naloxone in recent times. The presence of a large host of sellers of naloxone under licensed agreements has led to the maturity of the global naloxone market in recent times.

Global Naloxone Market: Trends and Opportunities

The research sector has been the fountainhead of growth within the healthcare and pharmaceutical industries. Although the application of naloxone for humans is in healthcare industry, the drug is primarily required in the research sector foe the study of its properties. Hence, is expected that the demand within the global naloxone market would increase as the research sector gathers momentum across the world. Furthermore, the efforts of healthcare professionals to prevent withdrawal symptoms of opiods in individuals have led them to prescribe naloxone along with other drugs.

It is projected that the total revenues within the global market for naloxone would increase as the pharmaceutical industry becomes an extensive consumer of naloxone. Furthermore, the presence of a robust healthcare sector, coupled with the research expertise of scientists, is also expected to reek of growth within the global naloxone market.

Global Naloxone Market: Regional Analysis

The demand within the naloxone market in Asia Pacific has been rising on account of the recurring prescription of various types of drugs for medical and healthcare purposes. Furthermore, the presence of an astral research sector in the US and Canada has given an impetus to the growth of the market for naloxone in North America. Other key regional markets for naloxone such as the Middle East and Africa and Latin America are also expected to grow at a robust rate in the forthcoming years.

Order this Report TOC for Detailed Statistics

Global Naloxone Market: Competitive Landscape

Mylan N.V.,

Kaleo, Inc.,

Hospira (Pfizer, Inc.),

Adapt Pharma, 

Amphastar Pharmaceuticals, Inc.

Rising Application of Naloxone in Pharmaceutical Industry to Boost Global Naloxone Market

Naloxone is a type of medication that is widely used to reverse the excessive effect or overdose of opioid. Opioid is a type of drug that includes heroine. Opioids are also present in synthetic opioids including fentanyl and pain relievers such as codeine, hydrocodone, morphine, and others that are legally prescribed and freely available in the market. Across the pharmaceutical industry, naloxone is widely used as it effectively suppresses the effect of opioids. Opioids are mixed with naloxone to balance drug dose to patients. In order to control and maintain the overdose of opioids naloxone is used significantly. Moreover, various medical research organizations and centers are making constant efforts to find out more properties of naloxone. The aforementioned factors are expected to drive the demand in the naloxone market in the coming years.

Get Sample Copy of this Report @

Approval of Candidate Drugs May Pose Strong Growth Opportunities for Naloxone Market

Various regulatory bodies are now approving new naloxone products that are likely to open several new opportunities for the global naloxone market. For instance, Mylan N.V. launched its new naloxone hydrochloride injection USP. This product is medicinally equivalent to the naloxone hydrochloride injection 0.4 mg/mL generated by Hospira Inc. Another example is when in the 2017, FDA approved Adapt Pharma Inc.’s NARCAN Nasal Spray 2 mg formulation to be used in times of emergency treatments for known or suspected opioid overdose. Thus, these growing efforts by various companies and research centers are projected to expand the naloxone market in the coming years.

Growing demand in emerging economies in Aisa Pacific is another driving factor boosting the demand in the global naloxone market. Recurring prescription of various types of drugs for medical and healthcare purposes in the region will benefit the market. On the other hand, North America is likely to hold a dominant position in the market. The presence of renowned research centers and rising availability of novel naloxone products made this region lead the market.

Read Comprehensive Overview of Report @